Imatinib vs Sitagliptin
Imatinib vs Sitagliptin: Overview
This comparison examines the pharmacological differences between Imatinib and Sitagliptin.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Sitagliptin: DPP-4 inhibitor increasing incretin levels.
Pharmacokinetics
Half-life: Imatinib β 18 hours; Sitagliptin β 12.4 hours.
Chemical Properties
Molecular Formula: Imatinib β C29H31N7O; Sitagliptin β C16H15F6N5O.
Molecular Weight: Imatinib β 493.6030 g/mol; Sitagliptin β 407.3140 g/mol.
Type: Imatinib β Small molecule; Sitagliptin β Small molecule.